Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Diffuse midline gliomas (DMGs) are some of the most aggressive and deadly childhood brain tumors. These cancers, which mainly ...

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with immunotherapies such as checkpoint inhibitors, due to the limitations ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

These can be classified in to those directed against cytokines involved in cell proliferation, survival and differentiation (i.e., IL-2, IL-4, IL-9 and IL-12), and those linked to the inflammatory ...

The work of University of Adelaide research fellow Dr Kevin Fenix has been boosted by a grant from the Cure Cancer Australia ...

This sensitized other dendritic cells and macrophages in the tumor environment to topical imiquimod therapy, which inhibited the formation of new blood vessels via the cytokine IL12 leading to the ...

Immunotherapy. 2012;4(1):107-120 ... characterized by the production of different cytokines and associated with protective, nonprotective or regulatory responses to infection.

A total of 10 study participants experienced low-grade cytokine release syndrome, a side effect of immunotherapy that was managed with additional treatments. None of the patients experienced ...

The cytokine IL-33 and ILC2 immune cells are ... 33's anti-cancer function and how this molecule could be harnessed for immunotherapy. Dr. Balachandran's team found an association between markers ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...